RBC Europe’s Usana Health Sciences USNA Stock Holding History

RBC Europe’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-110	Closed	-$8.48K	–	1237
2020 Q4	$8.48K	Hold	110	–	–	﹤0.01%	904
2020 Q3	$8.1K	Hold	110	–	–	﹤0.01%	835
2020 Q2	$8.08K	Hold	110	–	–	﹤0.01%	805
2020 Q1	$6.35K	Hold	110	–	–	﹤0.01%	793
2019 Q4	$8.64K	Hold	110	–	–	﹤0.01%	825
2019 Q3	$7.52K	Hold	110	–	–	﹤0.01%	838
2019 Q2	$8.74K	Hold	110	–	–	﹤0.01%	830
2019 Q1	$9.23K	Hold	110	–	–	﹤0.01%	836
2018 Q4	$12.9K	Hold	110	–	–	﹤0.01%	729
2018 Q3	$13.3K	Hold	110	–	–	﹤0.01%	778
2018 Q2	$12.7K	Hold	110	–	–	﹤0.01%	798
2018 Q1	$9.45K	Hold	110	–	–	﹤0.01%	844
2017 Q4	$8.15K	Hold	110	–	–	﹤0.01%	871
2017 Q3	$6.35K	Buy	+110	New	+$6.5K	﹤0.01%	917

Other funds holding USNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

RBC Europe's USNA Position: Q1 2021 in Review

RBC Europe sold out of Usana Health Sciences (USNA) in Q1 2021, closing a stake of 110 shares — an estimated $8.48K sold.

RBC Europe first reported a position in USNA in Q3 2017 and held it in 14 quarters. The position peaked at $13.3K in Q3 2018. 198 funds tracked by Wall St. Rank hold USNA as of Q1 2021.

RBC Europe reported no remaining Usana Health Sciences position as of Q1 2021 after selling out during the quarter.
RBC Europe sold 110 Usana Health Sciences shares in Q1 2021, an estimated $8.48K.
RBC Europe first reported a position in Usana Health Sciences in Q3 2017 and held it in 14 quarters.
RBC Europe's Usana Health Sciences position peaked at $13.3K in Q3 2018.
198 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2021.

Based on RBC Europe's 13F filing for Q1 2021, filed 9 Nov 2023.